Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-TAP vs Intraperitoneal Bupivacaine for Pain Control in Laparoscopic Cholecystectomy
NCT06714279Phase 1Recruiting
- Sponsor
- Royal College of Surgeons of England
- Start
- Mar 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of bupivacaine in postoperative pain (2 arms), sponsored by Royal College of Surgeons of England. Primary endpoint: Visual Analogue Scale at 24 hours. Started Mar 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06714279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06714279.